PDT Partners’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.84M | Sell |
196,550
-263,696
| -57% | -$2.47M | 0.1% | 318 |
|
|
2025
Q1 | $3.27M | Buy |
460,246
+132,638
| +40% | +$943K | 0.23% | 141 |
|
|
2024
Q4 | $3.82M | Buy |
327,608
+312,794
| +2,111% | +$3.65M | 0.34% | 83 |
|
|
2024
Q3 | $304K | Sell |
14,814
-212,406
| -93% | -$4.36M | 0.03% | 602 |
|
|
2024
Q2 | $5.09M | Buy |
227,220
+4,249
| +2% | +$95.1K | 0.48% | 27 |
|
|
2024
Q1 | $6.13M | Buy |
222,971
+61,974
| +38% | +$1.7M | 0.58% | 18 |
|
|
2023
Q4 | $4.91M | Buy |
160,997
+123,920
| +334% | +$3.78M | 0.54% | 28 |
|
|
2023
Q3 | $1.17M | Buy |
+37,077
| New | +$1.17M | 0.15% | 243 |
|
|
2021
Q4 | – | Sell |
-24,300
| Closed | -$3.26M | – | 970 |
|
|
2021
Q3 | $3.26M | Sell |
24,300
-26,900
| -53% | -$3.61M | 0.23% | 192 |
|
|
2021
Q2 | $8.29M | Sell |
51,200
-2,737
| -5% | -$443K | 0.55% | 4 |
|
|
2021
Q1 | $4.33M | Sell |
53,937
-36,463
| -40% | -$2.93M | 0.31% | 107 |
|
|
2020
Q4 | $4.92M | Buy |
90,400
+6,891
| +8% | +$375K | 0.33% | 127 |
|
|
2020
Q3 | $1.66M | Sell |
83,509
-18,634
| -18% | -$370K | 0.11% | 235 |
|
|
2020
Q2 | $2.15M | Sell |
102,143
-957
| -0.9% | -$20.1K | 0.15% | 206 |
|
|
2020
Q1 | $1.26M | Buy |
103,100
+17,583
| +21% | +$215K | 0.1% | 202 |
|
|
2019
Q4 | $1.26M | Buy |
85,517
+27,317
| +47% | +$401K | 0.08% | 245 |
|
|
2019
Q3 | $777K | Sell |
58,200
-88
| -0.2% | -$1.18K | 0.05% | 297 |
|
|
2019
Q2 | $954K | Buy |
+58,288
| New | +$954K | 0.06% | 258 |
|
|
2019
Q1 | – | Sell |
-87,743
| Closed | -$1.2M | – | 481 |
|
|
2018
Q4 | $1.2M | Buy |
87,743
+17
| +0% | +$232 | 0.07% | 255 |
|
|
2018
Q3 | $2.51M | Sell |
87,726
-18,783
| -18% | -$538K | 0.1% | 213 |
|
|
2018
Q2 | $2.91M | Sell |
106,509
-8,745
| -8% | -$239K | 0.11% | 209 |
|
|
2018
Q1 | $2.43M | Buy |
+115,254
| New | +$2.43M | 0.08% | 248 |
|